Document:

Exhibit
      10.1

    

    THE
      SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
      ACT
      OF 1933, AS AMENDED. SUCH SECURITIES AND ANY SECURITIES OR SHARES ISSUED
      HEREUNDER MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION
      OR
      AN EXEMPTION THEREFROM UNDER SAID ACT. 

     

    SIONIX
      CORPORATION

     

    AMENDED
      AND RESTATED CONVERTIBLE PROMISSORY NOTE

     

    
      	
              $_________________

            	
              January
                22, 2008

            

    

     

    This
      Amended and Restated Convertible Promissory Note amends and restates in its
      entirety the Convertible Promissory Note dated June 6, 2007, in the principal
      amount of $___________, made by the Company in favor of the Holder (each as
      defined below).

     

    SIONIX
      CORPORATION (the
      “Company”),
      a
      Nevada corporation, for value received, promises to pay to
      ______________________, a _______________ having a place of business at
      __________________________________, or its assign (___________________ or its
      assign is hereinafter referred to as the “Holder”)
      the
      principal sum of ________________ ($_____________) (the “Principal
      Amount”),
      plus
      simple interest thereon accruing from June 6, 2007 at the rate of ten percent
      (10.00%) per annum (the “Base
      Rate”),
      and
      such interest to be payable at the Maturity Date (as hereinafter defined) or
      upon the earlier acceleration of this Note as provided herein, provided that,
      upon an Event of Default (as defined below), the interest rate shall increase
      to
      the lower of twelve percent (12%) per annum or the maximum amount allowed by
      law
      to be charged for interest hereunder (the “Default
      Rate”),
      and
      continuing up through the date on which such Event of Default is cured to
      Holder’s satisfaction, after which the interest rate shall return to the Base
      Rate. 

     

    This
      Note
      will automatically mature and the entire outstanding Principal Amount, together
      with all unpaid and accrued interest, shall become due and payable upon the
      earlier of (i) the occurrence of an Event of Default or (ii) the Maturity Date,
      unless, prior to such time, this Note shall have been converted into shares
      of
      the Company’s capital stock pursuant to Section 1
      hereof.
      As used herein, “Maturity
      Date”
means
      such date, which shall be a Business Day (as hereinafter defined) that is not
      sooner than December 31, 2008, as the Holder may specify in written notice
      delivered to the Company not less than thirty (30) days prior to such specified
      date, and “Business
      Day”
means
      any day other than a Saturday, Sunday or other day on which banking institutions
      are authorized or required to be closed in New York, New York. The Company
      may
      not prepay this Note or any portion hereof (including, without limitation,
      any
      accrued but unpaid interest) except with the prior written consent of the
      Holder.

     

    Payments
      of both the Principal Amount and interest are to be made to the Holder in lawful
      money of the United Sates of America at the address of the Holder set forth
      in
Section 7(d)
      below or
      at such other place in the United States as the Holder shall designate to the
      Company in writing. Interest on this Note shall be computed on the basis of
      a
      360-day year consisting of twelve 30-day months.

     

    The
      following is a statement of the rights of the Holder and the conditions to
      which
      this Note is subject, and to which the Holder, by the acceptance of this Note,
      agrees:

     

    
      
         

      

      
        -1-

        
          

        

      

      
         

      

    

    1.  
Conversion.

     

    (a)  Optional
      Conversion.
      At any
      time prior to the payment of this Note in full, the outstanding Principal Amount
      and accrued and unpaid interest of this Note may be converted in whole or in
      part, at the option of the Holder, into (i) shares of common stock of the
      Company (“Common
      Stock”)
      at a
      conversion price of one cent ($0.01) per share (the “Conversion
      Price”)
      or
      (ii) shares of any equity security issued by the Company at a conversion price
      equal to the price at which such security is sold to any other party;
provided,
      however,
      that
      the Conversion Price shall be adjusted in accordance with Sections
      1(b),
      (c),
      (d)
      and
(e)
      hereof,
      and the Company shall deliver notice of such adjustment to the Holder in
      accordance with Section
      1(f)
      hereof.
      Notwithstanding anything contained herein to the contrary, the Holder’s right to
      convert this Note, or any portion or portions hereof, shall be subject to such
      conditions as are set forth in
      Exhibit B
      attached
      hereto and made a part hereof. 

     

    (b)  Adjustments
      to Conversion Price.
      In the
      event the Company shall at any time while this Note or any portion hereof
      remains outstanding issue Additional Shares of Common Stock (as hereinafter
      defined), without consideration or for a consideration per share less than
      the
      Conversion Price in effect immediately prior to such issue (“Dilutive
      Issuance”),
      then
      the Conversion Price shall be adjusted to the lowest issuance of each Dilutive
      Issuance, provided
      that
      if such
      issuance or deemed issuance was without consideration, then the Company shall
      be
      deemed to have received an aggregate of one tenth of one cent ($0.001) of
      consideration for all such Additional Shares of Common Stock issued or deemed
      to
      be issued. For
      purposes of the foregoing paragraph, “Additional
      Shares of Common Stock”
shall
      mean any issuances of equity securities (or securities convertible into equity
      securities) of the Company, other than the following: 

     

    (i)  shares
      of
      Common Stock issued or issuable by reason of a dividend, stock split, split-up
      or other distribution of shares of Common Stock as described in Section
      1(c),
      (d)
      or
(e)
      hereof;

     

    (ii)  up
      to
      14,229,200 shares of Common Stock actually issued upon the exercise of stock
      options;

     

    (iii)  up
      to an
      additional 13,981,770 shares of Common Stock (for a total of 28,210,970,
      including the stock option grants set forth in (ii) above) actually issued
      upon
      the exercise, exchange or conversion of options, warrants, convertible and
      other
      securities outstanding as of the date hereof and as set forth on Exhibit
      A
      attached
      hereto and made a part hereof, in each case provided such issuance is pursuant
      to the terms of such option or convertible security;

     

    (iv)  shares
      of
      the Company’s Common Stock issued in connection with a financing with a
      commercial bank or other lending institution as approved by the Board of
      Directors of the Company; 

     

    (v)  shares
      of
      Common Stock of the Company issued pursuant to a merger or consolidation with
      another party so long as the Company is the surviving entity, and provided
      that
      such merger or acquisition does not result in the transfer of fifty percent
      (50%) or more of the outstanding securities of the Company; or

     

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

    (vi)  shares
      of
      Common Stock issued in connection with a transaction where the Holder has
      indicated in writing that such transaction should be exempt from the
      anti-dilution adjustment provisions hereof.

     

    (c)  Adjustment
      for Stock Splits and Combinations.
      If the
      Company, at any time while this Note or any portion hereof remains outstanding,
      shall split, subdivide or combine the outstanding shares of Common Stock into
      a
      different number of shares of Common Stock, then (i) in the case of a split
      or
      subdivision, the Conversion Price for such securities shall be proportionately
      decreased and the shares of Common Stock issuable upon conversion of this Note
      shall be proportionately increased, and (ii) in the case of a combination,
      the
      Conversion Price shall be proportionately increased and the securities issuable
      upon conversion of this Note shall be proportionately decreased.

     

    (d)  Adjustments
      for Dividends in Stock or Other Securities or Property.
      If,
      while this Note or any portion hereof remains outstanding and unexpired, the
      holders of Common Stock, as applicable, shall have received or, on or after
      the
      record date fixed for the determination of eligible stockholders, shall have
      become entitled to receive, without payment therefor, additional shares of
      Common Stock, as applicable, by way of dividend, then and in each case this
      Note
      shall represent the right to convert, in addition to the number of shares of
      the
      security receivable upon exercise of this Note, and without payment of any
      additional consideration therefor, the amount of such additional shares of
      Common Stock, as applicable, that such holder would hold on the date of such
      conversion had it been the holder of record of that number of shares of Common
      Stock, as applicable, receivable upon exercise of this Note on the date hereof
      and had thereafter, during the period from the date hereof to and including
      the
      date of such exercise, retained such shares and/or all other additional stock
      available by it as aforesaid during such period, giving effect to all
      adjustments called for during such period by the provisions of this Section
      1.

     

    (e)  Reclassification,
      etc.
      If the
      Company, at any time while this Note or any portion hereof remains outstanding
      and unexpired, by reclassification of securities or otherwise, shall change
      any
      of the securities as to which conversion rights under this Note exist into
      the
      same or a different number of securities of any other class or classes, this
      Note shall thereafter represent the right to acquire such number and kind of
      securities as would have been issuable as the result of such change with respect
      to the securities that were subject to the purchase rights under this Note
      immediately prior to such reclassification or other change and the Conversion
      Price therefor shall be appropriately adjusted, all subject to further
      adjustment as provided in this Section
      1.

     

    (f)  Notices.
      Whenever the Conversion Price or number of shares purchasable hereunder shall
      be
      adjusted pursuant to subsection
      1(b),
      (c),
      (d)
      or
(e)
      hereof,
      the Company shall promptly issue a certificate to the Holder, signed by the
      Chief Financial Officer of the Company, setting forth, in reasonable detail,
      the
      event requiring the adjustment, the amount of the adjustment, the method by
      which the adjustment was calculated and the Conversion Price and number of
      shares issuable hereunder after giving effect to such adjustment.

     

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

    

    2.  
Mechanics
      of Conversion.

     

    (a)  Fractional
      Shares.
      No
      fractional shares of Common Stock shall be issued upon conversion of this Note.
      In lieu of any fractional shares to which the Holder would otherwise be
      entitled, the Company shall pay cash equal to such fraction multiplied by the
      Conversion Price.

     

    (b)  Stock
      Certificates.
      The
      Company shall, as soon as practicable thereafter, issue and deliver to the
      Holder, or to its nominee or nominees, a certificate or certificates for the
      number of shares of Common Stock to which it shall be entitled as aforesaid.
      Such conversion shall be deemed to have been made, as applicable, immediately
      prior to the close of business on the date of the closing of the transaction
      which causes the automatic conversion set forth above in Section 1.
      The
      person or persons entitled to receive the shares of Common Stock issuable upon
      such conversion shall be treated for all purposes as the record holders of
      such
      shares of Common Stock on such date.

     

    3.  
Default
      and Remedies.

     

    (a)  Event
      of Default.
      An
“Event
      of Default”
shall
      exist under this Note upon the happening of any of the following events or
      conditions, without demand or notice from the Holder:

     

    (i)  failure
      to make any payments required hereunder within three (3) business days of (A)
      such payment becoming due or (B) following notice given in accordance with
      the
      terms of this Note;

     

    (ii)  failure
      to observe or perform any of the agreements, warranties, representations or
      covenants in this Note, which failure results in a material adverse effect
      upon
      the Company and is not cured within thirty (30) days after the receipt of
      written notice thereof by the Holder;

     

    (iii)  any
      petition in bankruptcy being filed by or against the Company or any proceedings
      in bankruptcy, insolvency or under any other laws relating to the relief of
      debtors being commenced for the relief or readjustment of any indebtedness
      of
      the Company, either through reorganization, composition, extension or otherwise,
      and which, in the case of any involuntary proceedings, shall be acquiesced
      to by
      the Company or shall continue for a period of ninety (90) days undismissed,
      undischarged or unbonded;

     

    (iv)  the
      making by the Company of an assignment for the benefit of creditors, which
      assignment results in a material adverse effect upon the Company and is not
      cured within thirty (30) days after the receipt of written notice thereof by
      the
      Holder; 

     

    (v)  the
      appointment of a receiver of any property of the Company which shall not be
      vacated or removed within ninety (90) days after appointment; or

     

    (vi)  upon
      the
      date thirty (30) days following the occurrence of any event of default under
      the
      terms of any of the Company’s indebtedness or the acceleration of any
      indebtedness of the Company, which occurrence or acceleration results in a
      material adverse effect upon the Company.

     

    
      
         

      

      
        -4-

        
          

        

      

      
         

      

    

    (b)  Remedies.
      Upon
      the occurrence of an Event of Default under Section
      3(a)
      hereof,
      at the option and upon the declaration of the Holder, the entire unpaid
      Principal Amount and accrued and unpaid interest on this Note shall, without
      presentment, demand, protest or notice of any kind, all of which are hereby
      expressly waived, be forthwith due and payable, and the Holder may immediately
      and without expiration of any period of grace, enforce payment of all amounts
      due and owing under this Note and exercise any and all other remedies granted
      to
      it at law, in equity or otherwise. 

     

    4.  
Charges,
      Taxes and Expenses.
      Issuance of a certificate for shares of Common Stock upon the conversion of
      this
      Note shall be made without charge to the Holder for any issue or transfer tax
      or
      other incidental expense in respect of the issuance of such certificate, all
      of
      which taxes and expenses shall be paid by the Company, and such certificate
      shall be issued in the name of the Holder, or such certificates shall be issued
      in such name or names as may be directed by the Holder; provided,
      however,
      that in
      the event certificates for shares of Common Stock (or replacement Notes) are
      to
      be issued in a name other than the name of the Holder, this Note when
      surrendered for exercise or transfer shall be accompanied by the Assignment
      Form
      attached hereto duly executed by the Holder; and provided further,
      that
      upon any transfer involved in the issuance or delivery of any certificates
      for
      shares of Common Stock or replacement the Note, the Company may require, as
      a
      condition thereto, the payment of a sum sufficient to reimburse it for any
      transfer tax incidental thereto. Any transfer shall be subject to (i) the
      transferee’s agreement in writing to be subject to the applicable terms of this
      Note and (ii) compliance with all applicable state and federal securities
      laws (including the delivery of investment representation letters, legal
      opinions and market stand-off agreements reasonably
      satisfactory to the Company, if such are requested by the Company). The Holder
      agrees that the Holder shall execute such documents, and perform such acts,
      which are reasonably required to assure that the conversion hereof is
      consummated in compliance with all applicable laws.

     

    5.  
No
      Rights as Stockholder.
      This
      Note does not entitle the Holder to any voting rights or other rights as a
      stockholder of the Company prior to the conversion hereof.

     

    6.  
Loss,
      Theft or Destruction of Note.
      Upon
      receipt by the Company of evidence reasonably satisfactory to it of the loss,
      theft or destruction of this Note and of indemnity or security reasonably
      satisfactory to it, the Company will make and deliver a new Note, which shall
      carry the same rights to interest (unpaid and to accrue) carried by this Note,
      stating that such Note is issued in replacement of this Note, making reference
      to the original date of issuance of this Note (and any successors hereto) and
      dated as of such cancellation.

     

    7.  
Miscellaneous.

     

    (a)  Issue
      Date; Governing Law.
      The
      provisions of this Note shall be construed and shall be given effect in all
      respect as if it had been issued and delivered by the Company on the earlier
      of
      June 6, 2007 or the date of issuance of any Note for which this Note is issued
      in replacement. This Note shall be binding upon any successors or assigns of
      the
      Company. This Note shall constitute a contract under the laws of the State
      of
      New York and for all purposes shall be construed in accordance with and governed
      by the laws of said state.

     

    
      
         

      

      
        -5-

        
          

        

      

      
         

      

    

    (b)  Restrictions.
      The
      Holder acknowledges that the shares of capital stock acquired upon the
      conversion of this Note will be subject to restrictions upon resale imposed
      by
      state and federal securities laws.

     

    (c)  Assignment.
      Neither
      this Note nor any of the rights, interests or obligations hereunder may be
      assigned, by operation of law or otherwise, in whole or in part by the Holder
      to
      any person or entity without the prior written consent of the Company, except
      (assuming compliance with applicable state and federal securities laws) in
      connection with an assignment in whole to an affiliate of the Holder or to
      a
      successor corporation to the Holder resulting from a merger or consolidation
      of
      the Holder with or into another corporation or the sale of all or substantially
      all of the Holder’s properties and assets. Effective upon any such assignment,
      the person or entity to whom such rights, interests and obligations were
      assigned shall have and exercise all of the Holder’s rights, interest and
      obligations hereunder as if such person or entity were the original Holder
      of
      this Note.

     

    (d)  Notices.
      Any
      notice, request or other communication required or permitted hereunder shall
      be
      given upon personal delivery or upon the seventh day following mailing by
      registered airmail (or certified first class mail if both the addresser and
      addressee are located in the United States), postage prepaid and addressed
      to
      the parties as follows:

     

    
      	
              To
                the Company:

            	
              SIONIX
                Corporation

            
	
            	
              Airport
                Tower Plaza

            
	 	
              2082
                Michelson Drive Suite 304

            
	 	
              Irvine,
                CA 92612

            
	 	
              Attn:
                Richard Papalian, CEO

            
	 	 
	
              To
                the Holder:

            	
              At
                the address of the Holder set forth above or at such other address
                of
                which the Holder has given the Company written
                notice

            

    

     

    or
      to
      such other single place as any single addressee shall designate by written
      notice to the other addressee.

     

    
      	(e)      
               	
              Choice
                of Venue; Waiver of Right to Jury Trial.
                

            

    

     

    (i)  THIS
      NOTE
      AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE DEEMED MADE,
      EXECUTED, PERFORMED AND CONSTRUED IN ACCORDANCE WITH AND BE GOVERNED BY THE
      LAW
      OF THE STATE OF NEW YORK. ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS
      NOTE MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK OR OF THE UNITED
      STATES FOR THE SOUTHERN DISTRICT OF NEW YORK, IN EACH CASE WHICH ARE LOCATED
      IN
      THE COUNTY OF NEW YORK, AND, BY EXECUTION AND DELIVERY OF THIS NOTE, EACH PARTY
      HEREBY IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY
      AND UNCONDITIONALLY, THE NON-EXCLUSIVE JURISDICTION OF THE AFORESAID COURTS.
      EACH PARTY HEREBY FURTHER IRREVOCABLY WAIVES ANY CLAIM THAT ANY SUCH COURTS
      LACK
      PERSONAL JURISDICTION OVER SUCH PARTY, AND AGREES NOT TO PLEAD OR CLAIM IN
      ANY
      LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS NOTE BROUGHT IN ANY OF THE
      AFORESAID COURTS THAT ANY SUCH COURT LACKS PERSONAL JURISDICTION OVER SUCH
      PARTY. EACH PARTY FURTHER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OUT
      OF
      ANY OF THE AFOREMENTIONED COURTS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING
      OF COPIES THEREOF BY REGISTERED OR CERTIFIED MAIL, POSTAGE PREPAID, TO ANY
      SUCH
      PARTY AT ITS ADDRESS FOR NOTICES AS PROVIDED HEREIN, SUCH SERVICE TO BECOME
      EFFECTIVE 30 DAYS AFTER SUCH MAILING. EACH PARTY HEREBY IRREVOCABLY WAIVES
      ANY
      OBJECTION TO SUCH SERVICE OF PROCESS AND FURTHER IRREVOCABLY WAIVES AND AGREES
      NOT TO PLEAD OR CLAIM IN ANY ACTION OR PROCEEDING COMMENCED HEREUNDER THAT
      SUCH
      SERVICE OF PROCESS WAS IN ANY WAY INVALID OR INEFFECTIVE. NOTHING HEREIN SHALL
      AFFECT THE RIGHT OF THE PARTY UNDER THIS NOTE TO SERVE PROCESS IN ANY OTHER
      MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED
      AGAINST ANY PARTY IN ANY OTHER JURISDICTION.

     

    
      
         

      

      
        -6-

        
          

        

      

      
         

      

    

    (ii)  EACH
      PARTY HEREBY IRREVOCABLY WAIVES ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER
      HAVE
      TO THE LAYING OF VENUE OF ANY OF THE AFORESAID ACTIONS OR PROCEEDINGS ARISING
      OUT OF OR IN CONNECTION WITH THIS NOTE BROUGHT IN THE COURTS REFERRED TO IN
      CLAUSE (i) ABOVE AND HEREBY FURTHER IRREVOCABLY WAIVES AND AGREES NOT TO PLEAD
      OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY
      SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

     

    (iii)  EACH
      OF
      THE PARTIES TO THIS NOTE HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY
      JURY
      IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS
      NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY.

     

    (f)  
Enforcement.
      The
      Company shall pay all reasonable fees and expenses incurred by the Holder in
      the
      enforcement in any of the Company’s obligations hereunder not performed when
      due. In the event of a dispute with regard to the interpretation of this Note,
      the prevailing party shall be entitled to collect the cost of attorney’s fees,
      litigation expenses or such other expenses as may be incurred in the enforcement
      of the prevailing party’s rights hereunder.

     

    (g)  
Amendment
      or Waiver.
      This
      Note may only be amended with the prior written consent of the Holder and the
      Company.

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]

     

     

     

     

     

    
      
         

      

      
        -7-

        
          

        

      

      
         

      

    

     

    

    IN
      WITNESS WHEREOF, the undersigned has caused this Convertible Promissory Note
      to
      be executed by its officer thereunto duly authorized.

     

    COMPANY:

     

    SIONIX
      CORPORATION

     

    

     

    By:__________________________

    Name:
      Richard Papalian

    Title:  
      CEO

    

     

    
      
         

      

      
        -8-

        
          

        

      

      
         

      

    

    
EXHIBIT
      A

     

    Excluded
      Shares Of Common Stock

     

    SIONIX
      CORPORATION

    Shares
      Issued & To Be Issued

    

    
      	
              Issued
                & Outstanding per Books

            	 	 	 	 	 	
              103,505,622

            	 
	 	 	 	 	 	 	 	 
	
              2001
                Employee Stock Option Plan -

            	 	 	 	 	 	
              7,885,572

            	 
	
              SEC
                Form S-8 Dated 7/3/02

            	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
              Stock
                Options 

            	 	 	 	 	 	 	 
	
              James
                J. Houtz - (308,550/Qtr. X 20)

            	 	 	
              6,171,000

            	 	 	 	 
	
              Joan
                C. Houtz - (13,997/Qtr. X4)

            	 	 	
              55,988

            	 	 	 	 
	
              Robert
                E. McCray (29,160/Qtr. X4)

            	 	 	
              116,640

            	 	 	
              6,343,628

            	 
	 	 	 	 	 	 	 	 
	
              Stock
                Bonus Shares Returned

            	 	 	 	 	 	
              7,349,204

            	 
	 	 	 	 	 	 	 	 
	
              Purchase
                of R. J. Metals

            	 	 	 	 	 	
              2,769,230

            	 
	 	 	 	 	 	 	 	 
	
              Advisory
                Board Compensation

            	 	 	 	 	 	
              2,400,000

            	 
	 	 	 	 	 	 	 	 
	
              Shares
                for Cash/Option - Unissued

            	 	 	 	 	 	
              1,463,336

            	 
	 	 	 	 	 	 	 	 
	
              Total
                Shares To Be Issued

            	 	 	 	 	 	
              28,210,970

            	 
	 	 	 	 	 	 	 	 
	
              Total
                Shares Issued & To Be Issued

            	 	 	 	 	 	
              131,716,592

            	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 
	
              Issued
                & Outstanding per Registrar

            	 	 	 	 	 	
              102,524,186

            	 
	 	 	 	 	 	 	 	 
	
              Add:
                Shares for Cash - Unissued

            	 	 	 	 	 	
              1,463,336

            	 
	 	 	 	 	 	 	 	 
	
              Sub-Total

            	 	 	
              
              

            	 	 	
              103,987,522

            	 
	 	 	 	 	 	 	 	 
	
              Less:
                Cert. #1567 - J. Moorehead - Held

            	 	 	 	 	 	
              -481,900

            	 
	 	 	 	 	 	 	 	 
	
              Total
                Issued & Outstanding Shares

            	 	 	 	 	 	
              103,505,622

            	 

    

    

     

    And
      such
      additional shares as may be issued or issuable upon the exercise of any Secured
      Convertible Promissory Notes issued pursuant to that certain Secured Convertible
      Note Purchase Agreement, dated as of October 18, 2006, by and among the Company
      and certain purchasers identified therein.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    EXHIBIT
      B

     

    Condition
      to Exercise of Conversion Rights

     

    Notwithstanding
      anything in this Note to the contrary, the Holder shall be entitled to exercise
      the conversion rights under this Note with respect to the entire $_____________
      original principal amount hereof (plus the amount of accrued and unpaid interest
      on such amount) only upon and following the date when the gross proceeds
      received by the Company after December 30, 2007 and before December 31, 2008,
      which are retained by the Company as operating capital, from or with respect
      to
      any financing or financings (in any form, whether equity or debt, including
      any
      financing(s) provided by any bank or other institutional lender), or joint
      venture, purchase order, leasing agreement or licensing agreement, shall
      aggregate at least $2,000,000.  

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

 

    NOTICE
      OF CONVERSION

     

    (To
      convert the foregoing Note, execute this form and supply required
      information.)

     

    To: SIONIX
      CORPORATION

     

    (1) 
The
      undersigned hereby elects to convert the attached Convertible Promissory Note
      (the “Note”) into:

     

    
      	
              ________

            	
              __________
                shares of Common Stock of SIONIX CORPORATION pursuant to Section
                1(a) and
                the other applicable terms of the attached Note at a Conversion Price
                of $
                _______ per share (originally $0.01); or

            
	 	 
	
              ________

            	
              __________
                shares of ___________ of SIONIX CORPORATION pursuant to Section 1(a)
                and
                the other applicable terms of such Note at a Conversion Price of
                $ _____
                per share.

               

            

    

     

    (2) In
      converting this Note, the undersigned hereby confirms and acknowledges that
      the
      securities being issued hereby are being acquired solely for the account of
      the
      undersigned and not as a nominee for any other party, or for investment, and
      that the undersigned will not offer, sell or otherwise dispose of any such
      securities, except under circumstances that will not result in a violation
      of
      the Securities Act of 1933, as amended, or any applicable state securities
      laws.

     

    (3) Please
      issue a certificate or certificates representing said securities in the name
      of
      the undersigned: 

     

    
      

      
        	
              	 	_____________________
	
              	
              	
                (Name)

              

      

    

     

    (4) Capitalized
      terms used herein shall have the meanings ascribed to them in the
      Note.

     

    
      	_______________ 	 	_____________________
	
              (Date)

            	
            	
              (Signature)

            
	 	 	 
	 	 	_____________________
	 	 	
              (Print
                Name)

            

    

    

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    ASSIGNMENT
      FORM

     

    (To
      be
      signed only upon assignment of the Note)

    

    FOR
      VALUE
      RECEIVED, the undersigned hereby sells, assigns and transfers unto the assignee
      named below all of the rights of the undersigned represented by the attached
      Note with respect to the amount of principal covered by such Note set forth
      below: 

    

    
      
        

      

    

    (Name
      and
      Address of Assignee Must be Printed or Typewritten)

    

    
      	
              _________________

            	
              _____________________________

            	
              ______________

            
	
              Social
                Security No.

            	
              Address

            	
              Principal
                Amount

            
	
              or
                Tax ID No.

            	 	 

    

    

    and
      does
      hereby irrevocably constitute and appoint _________ Attorney to transfer said
      Note on the books of the Company, with full power of substitution in the
      premises.

     

    Dated:
      

    

    _________________________

    Signature
      of Registered Holder

    

    Note:
      The
      signature on this assignment must correspond with the name of the Holder as
      it
      appears upon the face of the Note in every particular, without alteration or
      enlargement or any change whatever.SECURITIES
      PURCHASE AGREEMENT

     

    This
      Securities Purchase Agreement (this “Agreement”)
      is
      dated as of January 25, 2008, among Organic To Go Food Corporation, a Delaware
      corporation (the “Company”),
      and
      the investors listed on the Schedule of Buyers attached hereto as Annex
      A
      and
      identified on the signature pages hereto (each, an “Investor”
      and
      collectively, the “Investors”).

     

    WHEREAS,
      subject to the terms and conditions set forth in this Agreement and pursuant
      to
      Section 4(2) of the Securities Act (as defined below) and Rule 506 promulgated
      thereunder, the Company desires to issue and sell to each Investor, and each
      Investor, severally and not jointly, desires to purchase from the Company
      certain securities of the Company, as more fully described in this
      Agreement.

     

    NOW,
      THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
      and for other good and valuable consideration the receipt and adequacy of which
      are hereby acknowledged, the Company and the Investors agree as
      follows:

     

    ARTICLE
      1.

    DEFINITIONS

     

    1.1. Definitions.
      In
      addition to the terms defined elsewhere in this Agreement, for all purposes
      of
      this Agreement, the following terms shall have the meanings indicated in this
      Section 1.1:

     

    “Action”
      means
      any action, suit, inquiry, notice of violation, proceeding (including any
      partial proceeding such as a deposition) or investigation pending or threatened
      in writing against or affecting the Company, any Subsidiary or any of their
      respective properties before or by any court, arbitrator, governmental or
      administrative agency, regulatory authority (federal, state, county, local
      or
      foreign), stock market, stock exchange or trading facility.

     

    “Affiliate”
      means
      any Person that, directly or indirectly through one or more intermediaries,
      controls or is controlled by or is under common control with a Person, as such
      terms are used in and construed under Rule 144.

     

    “Business
      Day”
      means
      any day except Saturday, Sunday and any day which is a federal legal holiday
      in
      the United States or a day on which banking institutions in the State of New
      York or State of Washington are authorized or required by law or other
      governmental action to close.

     

    “Buy-In”
has
      the
      meaning set forth in Section 4.1(c).

     

    “Closing”
      means
      the closing of the purchase and sale of the Securities pursuant to Article
      II.

     

    “Closing
      Date”
      means
      the Business Day on which all of the conditions set forth in Sections 5.1 and
      5.2 hereof are satisfied, or such other date as the parties may
      agree.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    “Commission”
      means
      the Securities and Exchange Commission.

     

    “Common
      Stock”
      means
      the common stock of the Company, par value $0.001 per share, and any securities
      into which such common stock may hereafter be reclassified.

     

    “Common
      Stock Equivalents”
      means
      any securities of the Company or any Subsidiary which entitle the holder thereof
      to acquire Common Stock at any time, including without limitation, any debt,
      preferred stock, rights, options, warrants or other instrument that is at any
      time convertible into or exchangeable for, or otherwise entitles the holder
      thereof to receive, Common Stock or other securities that entitle the holder
      to
      receive, directly or indirectly, Common Stock.

     

    “Company
      Counsel”
      means
      Loeb & Loeb LLP.

     

    “Company
      Deliverables”
      has the
      meaning set forth in Section 2.2(a).

     

    “Disclosure
      Materials”
      has the
      meaning set forth in Section 3.1(h).

     

    “Evaluation
      Date”
      has the
      meaning set forth in Section 3.1(s).

     

    “Exchange
      Act”
      means
      the Securities Exchange Act of 1934, as amended.

     

    “GAAP”
      means
      U.S. generally accepted accounting principles.

     

    “Intellectual
      Property Rights”
      has the
      meaning set forth in Section 3.1(p).

     

    “Investment
      Amount”
      means,
      with respect to each Investor, the Investment Amount indicated on such
      Investor’s signature page to this Agreement.

     

    “Investor
      Deliverables”
      has the
      meaning set forth in Section 2.2(b).

     

    “Investor
      Party”
      has the
      meaning set forth in Section 4.7.

     

    “Lien”
      means
      any lien, charge, encumbrance, security interest, right of first refusal or
      other restrictions of any kind.

     

    “Losses”
has
      the
      meaning set forth in Section 4.7.

     

    “Material
      Adverse Effect”
      means
      any of (i) a material and adverse effect on the legality, validity or
      enforceability of any Transaction Document, (ii) a material and adverse effect
      on the results of operations, assets, prospects, business or condition
      (financial or otherwise) of the Company and the Subsidiaries, taken as a whole,
      or (iii) an adverse impairment to the Company’s ability to perform on a timely
      basis its obligations under any Transaction Document.

     

    “New
      York Courts”
      means
      the state and federal courts sitting in the City of New York, Borough of
      Manhattan.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    “Outside
      Date”
      means
      the thirtieth day following the date of this Agreement.

     

    “Per
      Unit Purchase Price”
      equals
      $1.40.

     

    “Person”
      means an
      individual or corporation, partnership, trust, incorporated or unincorporated
      association, joint venture, limited liability company, joint stock company,
      government (or an agency or subdivision thereof) or other entity of any
      kind.

     

    “Preferred
      Investor”
has
      the
      meaning set forth in Section 4.11(a).

     

    “Proceeding”
      means an
      action, claim, suit, investigation or proceeding (including, without limitation,
      an investigation or partial proceeding, such as a deposition), whether commenced
      or threatened.

     

    “Rule
      144”
      means
      Rule 144 promulgated by the Commission pursuant to the Securities Act, as such
      Rule may be amended from time to time, or any similar rule or regulation
      hereafter adopted by the Commission having substantially the same effect as
      such
      Rule.

     

    “SEC
      Reports”
      has the
      meaning set forth in Section 3.1(h).

     

    “Securities”
      means
      the Shares, the Warrants and the Warrant Shares.

     

    “Securities
      Act”
      means
      the Securities Act of 1933, as amended.

     

    “Share
      Delivery Date”
has
      the
      meaning set forth in Section 4.1(c).

     

    “Shares”
      means
      the shares of Common Stock issued or issuable to the Investors pursuant to
      this
      Agreement.

     

    “Short
      Sales”
      include,
      without limitation, all “short sales” as defined in Rule 200 promulgated under
      Regulation SHO under the Exchange Act and all types of direct and indirect
      stock
      pledges, forward sale contracts, options, puts, calls, swaps and similar
      arrangements (including on a total return basis), and sales and other
      transactions through non-US broker dealers or foreign regulated
      brokers.

     

    “Subsidiary”
      means
      any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X
      promulgated by the Commission under the Exchange Act.

     

    “Trading
      Day”
      means
      (i) a day on which the Common Stock is traded on a Trading Market (other than
      the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading
      Market (other than the OTC Bulletin Board), a day on which the Common Stock
      is
      traded in the over-the-counter market, as reported by the OTC Bulletin Board,
      or
      (iii) if the Common Stock is not quoted on any Trading Market, a day on which
      the Common Stock is quoted in the over-the-counter market as reported by the
      Pink Sheets LLC (or any similar organization or agency succeeding to its
      functions of reporting prices); provided, that in the event that the Common
      Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then
      Trading Day shall mean a Business Day.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    “Trading
      Market”
      means
      whichever of the New York Stock Exchange, the American Stock Exchange, the
      NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market
      or OTC Bulletin Board on which the Common Stock is listed or quoted for trading
      on the date in question.

     

    “Transaction
      Documents”
      means
      this Agreement, the Warrants and any other documents or agreements executed
      in
      connection with the transactions contemplated hereunder.

     

    “Warrants”
      means
      the
      Common Stock purchase warrants in the form of Exhibit
      A,
      which
      are issuable to the Investors at the Closing.

     

    “Warrant
      Shares” means
      the
      shares of Common Stock issuable upon exercise of the Warrants.

     

    ARTICLE
      2.

    PURCHASE
      AND SALE

     

    2.1. Closing.
      Subject to the terms and conditions set forth in this Agreement, at the Closing,
      the Company shall issue and sell to each Investor, and each Investor shall,
      severally and not jointly, purchase from the Company, the Shares and the
      Warrants representing such Investor’s Investment Amount. The Closing shall take
      place at the offices of Loeb & Loeb LLP, 10100 Santa Monica Boulevard, Suite
      2200, Los Angeles, CA 90067 on the Closing Date or at such other location or
      time as the parties may agree.

     

    2.2. Closing
      Deliveries.
      (a) At the Closing, the Company shall deliver or cause to be delivered to each
      Investor the following (the “Company
      Deliverables”):

     

    (i) a
      certificate evidencing a number of Shares equal to such Investor’s Investment
      Amount divided by the Per Unit Purchase Price, registered in the name of such
      Investor; and

     

    (ii) a
      Warrant, registered in the name of such Investor, pursuant to which such
      Investor shall have the right to acquire the number of shares of Common Stock
      equal to 45% of the number of Shares issuable to such Investor pursuant to
      Section 2.2(a)(i);

     

    (b) At
      the
      Closing, each Investor shall deliver or cause to be delivered (the “Investor
      Deliverables”):

     

    (i) to
      the
      Company, such Investor’s Investment Amount, in United States dollars and in
      immediately available funds, by wire transfer to an account designated in
      writing by the Company.

     

    ARTICLE
      3.

     

    REPRESENTATIONS
      AND WARRANTIES

     

    3.1. Representations
      and Warranties of the Company.
      The Company hereby makes the following representations and warranties to each
      Investor:

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (a) Subsidiaries.
      The
      Company has no direct or indirect Subsidiaries other than as specified in the
      SEC Reports. Except as disclosed in Schedule
      3.1(a),
      the
      Company owns, directly or indirectly, all of the capital stock of each
      Subsidiary free and clear of any and all Liens, and all the issued and
      outstanding shares of capital stock of each Subsidiary are validly issued and
      are fully paid, non-assessable and free of preemptive and similar rights.

     

    (b) Organization
      and Qualification.
      The
      Company and each Subsidiary are duly incorporated or otherwise organized,
      validly existing and in good standing under the laws of the jurisdiction of
      its
      incorporation or organization (as applicable), with the requisite power and
      authority to own and use its properties and assets and to carry on its business
      as currently conducted. Neither the Company nor any Subsidiary is in violation
      of any of the provisions of its respective certificate or articles of
      incorporation, bylaws or other organizational or charter documents. The Company
      and each Subsidiary are duly qualified to conduct its respective businesses
      and
      are in good standing as a foreign corporation or other entity in each
      jurisdiction in which the nature of the business conducted or property owned
      by
      it makes such qualification necessary, except where the failure to be so
      qualified or in good standing, as the case may be, could not, individually
      or in
      the aggregate, have or reasonably be expected to result in a Material Adverse
      Effect.

     

    (c) Authorization;
      Enforcement.
      The
      Company has the requisite corporate power and authority to enter into and to
      consummate the transactions contemplated by each of the Transaction Documents
      and otherwise to carry out its obligations thereunder. The execution and
      delivery of each of the Transaction Documents by the Company and the
      consummation by it of the transactions contemplated thereby have been duly
      authorized by all necessary action on the part of the Company and no further
      action is required by the Company in connection therewith. Each Transaction
      Document has been (or upon delivery will have been) duly executed by the Company
      and, when delivered in accordance with the terms hereof, will constitute the
      valid and binding obligation of the Company enforceable against the Company
      in
      accordance with its terms, except as such enforceability may be limited by
      applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
      or
      similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general
      application.

     

    (d) No
      Conflicts.
      The
      execution, delivery and performance of the Transaction Documents by the Company
      and the consummation by the Company of the transactions contemplated thereby
      do
      not and will not (i) conflict with or violate any provision of the Company’s or
      any Subsidiary’s certificate or articles of incorporation, bylaws or other
      organizational or charter documents, or (ii) conflict with, or constitute a
      default (or an event that with notice or lapse of time or both would become
      a
      default) under, or give to others any rights of termination, amendment,
      acceleration or cancellation (with or without notice, lapse of time or both)
      of,
      any agreement, credit facility, debt or other instrument (evidencing a Company
      or Subsidiary debt or otherwise) or other understanding to which the Company
      or
      any Subsidiary is a party or by which any property or asset of the Company
      or
      any Subsidiary is bound or affected, or (iii) result in a violation of any
      law,
      rule, regulation, order, judgment, injunction, decree or other restriction
      of
      any court or governmental authority to which the Company or a Subsidiary is
      subject (including federal and state securities laws and regulations), or by
      which any property or asset of the Company or a Subsidiary is bound or affected;
      except in the case of each of clauses (ii) and (iii), such as could not,
      individually or in the aggregate, have or reasonably be expected to result
      in a
      Material Adverse Effect. 

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (e) Filings,
      Consents and Approvals.
      Neither
      the Company nor any Subsidiary is required to obtain any consent, waiver,
      authorization or order of, give any notice to, or make any filing or
      registration with, any court or other federal, state, local or other
      governmental authority or other Person in connection with the execution,
      delivery and performance by the Company of the Transaction Documents, other
      than
      (i) filings required by state securities laws, (ii) the filing of a Notice
      of
      Sale of Securities on Form D with the Commission under Regulation D of the
      Securities Act, (iii) the filings required in accordance with Section 4.5 and
      (iv) those that have been made or obtained prior to the date of this
      Agreement.

     

    (f) Issuance
      of the Securities.
      The
      Securities have been duly authorized and, when issued and paid for in accordance
      with the Transaction Documents, will be duly and validly issued, fully paid
      and
      nonassessable, free and clear of all Liens. The Company has reserved from its
      duly authorized capital stock the shares of Common Stock issuable pursuant
      to
      this Agreement and the Warrants in order to issue the Shares and the Warrant
      Shares.

     

    (g) Capitalization.
      The
      number of shares and type of all authorized, issued and outstanding capital
      stock of the Company, and all shares of Common Stock reserved for issuance
      under
      the Company’s various option and incentive plans, is specified in the SEC
      Reports. Except as specified in the SEC Reports, no securities of the Company
      are entitled to preemptive or similar rights, and no Person has any right of
      first refusal, preemptive right, right of participation, or any similar right
      to
      participate in the transactions contemplated by the Transaction Documents.
      Except as specified in the SEC Reports
      and
      except as set forth on Schedule
      3.1(g),
      there
      are no outstanding options, warrants, scrip rights to subscribe to, calls or
      commitments of any character whatsoever relating to, or securities, rights
      or
      obligations convertible into or exchangeable for, or giving any Person any
      right
      to subscribe for or acquire, any shares of Common Stock, or contracts,
      commitments, understandings or arrangements by which the Company or any
      Subsidiary is or may become bound to issue additional shares of Common Stock,
      or
      securities or rights convertible or exchangeable into shares of Common Stock.
      Except
      with respect to [2,040,446] warrants to purchase Common Stock, the
      issue
      and sale of the Securities will not, immediately or with the passage of time,
      obligate the Company or any Subsidiary to issue shares of Common Stock or other
      securities to any Person (other than the Investors) and will not result in
      a
      right of any holder of Company or Subsidiary securities to adjust the exercise,
      conversion, exchange or reset price under such securities.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    (h) SEC
      Reports; Financial Statements.
      Except
      as
      set forth on Schedule
      3.1(h),
      the
      Company
      has filed all reports required to be filed by it under the Securities Act and
      the Exchange Act, including pursuant to Section 13(a) or 15(d)
      thereof, for the twelve months preceding the date hereof (or such shorter period
      as the Company was required by law to file such reports) (the foregoing
      materials being collectively referred to herein as the “SEC
      Reports”
      and,
      together with the Schedules to this Agreement (if any), the “Disclosure
      Materials”),
      on a
      timely basis or has timely filed a valid extension of such time of filing and
      has filed any such SEC Reports prior to the expiration of any such extension.
      As
      of their respective dates, the SEC Reports complied in all material respects
      with the requirements of the Securities Act and the Exchange Act and the rules
      and regulations of the Commission promulgated thereunder, and none of the SEC
      Reports, when filed, contained any untrue statement of a material fact or
      omitted to state a material fact required to be stated therein or necessary
      in
      order to make the statements therein, in light of the circumstances under which
      they were made, not misleading. The financial statements of the Company and
      any
      Subsidiary included in the SEC Reports comply in all material respects with
      applicable accounting requirements and the rules and regulations of the
      Commission with respect thereto as in effect at the time of filing. Such
      financial statements have been prepared in accordance with GAAP applied on
      a
      consistent basis during the periods involved, except as may be otherwise
      specified in such financial statements or the notes thereto, and fairly present
      in all material respects the financial position of the Company and its
      consolidated Subsidiaries as of and for the dates thereof and the results of
      operations and cash flows for the periods then ended, subject, in the case
      of
      unaudited statements, to normal, immaterial, year-end audit
      adjustments.

     

    (i) Press
      Releases.
      The
      press
      releases
      disseminated by the Company since February
      13, 2007
      taken as
      a whole do not contain any untrue statement of a material fact or omit to state
      a material fact required to be stated therein or necessary in order to make
      the
      statements therein, in light of the circumstances under which they were made
      and
      when made, not misleading.

     

    (j) Material
      Changes.
      Since
      the
      date of the latest audited financial statements included within the SEC Reports,
      except as specifically
      disclosed in the SEC Reports and
      except as disclosed on Schedule
      3.1(j),
      (i)
      there has been no event, occurrence or development that has had or that could
      reasonably be expected to result in a Material Adverse Effect, (ii) neither
      the
      Company nor any Subsidiary has incurred any liabilities (contingent or
      otherwise) other than (A) trade payables, accrued expenses and other liabilities
      incurred in the ordinary course of business consistent with past practice and
      (B) liabilities not required to be reflected in the Company’s financial
      statements pursuant to GAAP or required to be disclosed in filings made with
      the
      Commission, (iii) neither the Company nor any Subsidiary has altered its method
      of accounting or the identity of its auditors, (iv) neither the Company nor
      any
      Subsidiary has declared or made any dividend or distribution of cash or other
      property to its stockholders or purchased, redeemed or made any agreements
      to
      purchase or redeem any shares of its capital stock, and (v) neither the Company
      nor any Subsidiary has issued any equity securities to any officer, director
      or
      Affiliate, except pursuant to existing stock option plans. The Company does
      not
      have pending before the Commission any request for confidential treatment of
      information.

     

    (k) Litigation.
      There
      is no Action which (i) adversely affects or challenges the legality, validity
      or
      enforceability of any of the Transaction Documents or the Securities or (ii)
      except as specifically disclosed in the SEC Reports, could, if there were an
      unfavorable decision, individually or in the aggregate, have or reasonably
      be
      expected to result in a Material Adverse Effect. Neither the Company nor any
      Subsidiary, nor any director or officer thereof (in his or her capacity as
      such), is or has been the subject of any Action involving a claim of violation
      of or liability under federal or state securities laws or a claim of breach
      of
      fiduciary duty, except as specifically disclosed in the SEC Reports. There
      has
      not been, and to the knowledge of the Company, there is not pending any
      investigation by the Commission involving the Company, any Subsidiary or any
      current or former director or officer of the Company (in his or her capacity
      as
      such). The Commission has not issued any stop order or other order suspending
      the effectiveness of any registration statement filed by the Company or any
      Subsidiary under the Exchange Act or the Securities Act.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (l) Labor
      Relations.
      No
      material labor dispute exists or, to the knowledge of the Company, is imminent
      with respect to any of the employees of the Company or any
      Subsidiary.

     

    (m) Compliance.
      Except
      as set forth on Schedule
      3.1(m),
      neither
      the Company nor any Subsidiary (i) is in default under or in violation of (and
      no event has occurred that has not been waived that, with notice or lapse of
      time or both, would result in a default by the Company or any Subsidiary under),
      nor has the Company or any Subsidiary received notice of a claim that it is
      in
      default under or that it is in violation of, any indenture, loan or credit
      agreement or any other agreement or instrument to which it is a party or by
      which it or any of its properties is bound (whether or not such default or
      violation has been waived), (ii) is in violation of any order of any court,
      arbitrator or governmental body, or (iii) is or has been in violation of any
      statute, rule or regulation of any governmental authority, including without
      limitation all foreign, federal, state and local laws relating to taxes,
      environmental protection, occupational health and safety, product quality and
      safety and employment and labor matters, except in each case as could not,
      individually or in the aggregate, have or reasonably be expected to result
      in a
      Material Adverse Effect. The Company is in compliance with all effective
      requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and
      regulations thereunder, that are applicable to it, except where such
      noncompliance could not have or reasonably be expected to result in a Material
      Adverse Effect.

     

    (n) Regulatory
      Permits.
      The
      Company and the Subsidiaries possess all certificates, authorizations and
      permits issued by the appropriate federal, state, local or foreign regulatory
      authorities necessary to conduct their respective businesses as described in
      the
      SEC Reports, except where the failure to possess such permits could not,
      individually or in the aggregate, have or reasonably be expected to result
      in a
      Material Adverse Effect, and neither the Company nor any Subsidiary has received
      any notice of proceedings relating to the revocation or modification of any
      such
      permits.

     

    (o) Title
      to Assets.
      Except
      as set forth on Schedule
      3.1(o),
      the
      Company and the Subsidiaries have good and marketable title in fee simple to
      all
      real property owned by them that is material to their respective businesses
      and
      good and marketable title in all personal property owned by them that is
      material to their respective businesses, in each case free and clear of all
      Liens, except for Liens as do not materially affect the value of such property
      and do not materially interfere with the use made and proposed to be made of
      such property by the Company and the Subsidiaries. Any real property and
      facilities held under lease by the Company and the Subsidiaries are held by
      them
      under valid, subsisting and enforceable leases of which the Company and the
      Subsidiaries are in compliance, except as could not, individually or in the
      aggregate, have or reasonably be expected to result in a Material Adverse
      Effect.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    (p) Patents
      and Trademarks.
      The
      Company and the Subsidiaries have, or have rights to use, all patents, patent
      applications, trademarks, trademark applications, service marks, trade names,
      copyrights, licenses and other similar rights that are necessary or material
      for
      use in connection with their respective businesses as described in the SEC
      Reports and which the failure to so have could, individually or in the
      aggregate, have or reasonably be expected to result in a Material Adverse Effect
      (collectively, the “Intellectual
      Property Rights”).
      Neither the Company nor any Subsidiary has received a written notice that the
      Intellectual Property Rights used by the Company or any Subsidiary violates
      or
      infringes upon the rights of any Person. Except as set forth in the SEC Reports,
      to the knowledge of the Company, all such Intellectual Property Rights are
      enforceable and there is no existing infringement by another Person of any
      of
      the Intellectual Property Rights.

     

    (q) Insurance.
      The
      Company and the Subsidiaries are insured by insurers of recognized financial
      responsibility against such losses and risks and in such amounts as are prudent
      and customary in the businesses in which the Company and the Subsidiaries are
      engaged. The Company has no reason to believe that it will not be able to renew
      its and the Subsidiaries’ existing insurance coverage as and when such coverage
      expires or to obtain similar coverage from similar insurers as may be necessary
      to continue its business on terms consistent with market for the Company’s and
      such Subsidiaries’ respective lines of business.

     

    (r) Transactions
      With Affiliates and Employees.
      Except
      as set forth in or otherwise not required to be disclosed in the SEC Reports,
      none of the officers or directors of the Company and, to the knowledge of the
      Company, none of the employees of the Company or any Subsidiary is presently
      a
      party to any transaction with the Company or any Subsidiary (other than for
      services as employees, officers and directors), including any contract,
      agreement or other arrangement providing for the furnishing of services to
      or
      by, providing for rental of real or personal property to or from, or otherwise
      requiring payments to or from any officer, director or such employee or, to
      the
      knowledge of the Company, any entity in which any officer, director, or any
      such
      employee has a substantial interest or is an officer, director, trustee or
      partner.

     

    (s) Internal
      Accounting Controls.
      The
      Company and the Subsidiaries maintain a system of internal accounting controls
      sufficient to provide reasonable assurance that (i) transactions are executed
      in
      accordance with management’s general or specific authorizations, (ii)
      transactions are recorded as necessary to permit preparation of financial
      statements in conformity with GAAP and to maintain asset accountability, (iii)
      access to assets is permitted only in accordance with management’s general or
      specific authorization, and (iv) the recorded accountability for assets is
      compared with the existing assets at reasonable intervals and appropriate action
      is taken with respect to any differences. The Company has established disclosure
      controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
      15d-15(e)) for the Company and designed such disclosure controls and procedures
      to ensure that material information relating to the Company, including its
      Subsidiaries, is made known to the certifying officers by others within those
      entities, particularly during the period in which the Company’s Form 10-KSB or
      10-QSB, as the case may be, is being prepared. The Company’s certifying officers
      have evaluated the effectiveness of the Company’s controls and procedures in
      accordance with Item 307 of Regulation S-B under the Exchange Act for the
      Company’s most recently ended fiscal quarter or fiscal year-end (such date, the
“Evaluation
      Date”).
      The
      Company presented in its most recently filed Form 10-KSB or Form 10-QSB the
      conclusions of the certifying officers about the effectiveness of the disclosure
      controls and procedures based on their evaluations as of the Evaluation Date.
      Since the Evaluation Date, there have been no significant changes in the
      Company’s internal controls (as such term is defined in Item 308(c) of
      Regulation S-B under the Exchange Act) or, to the Company’s knowledge, in other
      factors that could significantly affect the Company’s internal
      controls.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    (t) Solvency.
      Based
      on the financial condition of the Company and each Subsidiary as of the Closing
      Date (and assuming that the Closing shall have occurred), (i) the Company’s and
      each Subsidiary’s fair saleable value of its assets exceeds the amount that will
      be required to be paid on or in respect of the Company’s and each Subsidiary’s
      existing debts and other liabilities (including known contingent liabilities)
      as
      they mature, (ii) the Company’s and each Subsidiary’s assets do not constitute
      unreasonably small capital to carry on its business for the current fiscal
      year
      as now conducted and as proposed to be conducted including its capital needs
      taking into account the particular capital requirements of the business
      conducted by the Company and each Subsidiary, and projected capital requirements
      and capital availability thereof, and (iii) the current cash flow of the Company
      and each Subsidiary, together with the proceeds the Company and each Subsidiary
      would receive, were it to liquidate all of its assets, after taking into account
      all anticipated uses of the cash, would be sufficient to pay all amounts on
      or
      in respect of its debt when such amounts are required to be paid. The Company
      and each Subsidiary does not intend to incur debts beyond its ability to pay
      such debts as they mature (taking into account the timing and amounts of cash
      to
      be payable on or in respect of its debt). 

     

    (u) Certain
      Fees.
      Except
      as described in Schedule
      3.1(u),
      no
      brokerage or finder’s fees or commissions are or will be payable by the Company
      or any Subsidiary to any broker, financial advisor or consultant, finder,
      placement agent, investment banker, bank or other Person with respect to the
      transactions contemplated by this Agreement. The Investors shall have no
      obligation with respect to any fees or with respect to any claims (other than
      such fees or commissions owed by an Investor pursuant to written agreements
      executed by such Investor which fees or commissions shall be the sole
      responsibility of such Investor) made by or on behalf of other Persons for
      fees
      of a type contemplated in this Section that may be due in connection with the
      transactions contemplated by this Agreement.

     

    (v) Certain
      Registration Matters.
      Assuming the accuracy of the Investors’ representations and warranties set forth
      in Section 3.2(b)-(e), no registration under the Securities Act is required
      for
      the offer and sale of the Shares and Warrants, and the offer of the Warrant
      Shares, by the Company to the Investors under the Transaction Documents. The
      Company is eligible to register its Common Stock for resale by the Investors
      under Form SB-2 promulgated under the Securities Act. Except as specified in
      the
      SEC Reports and except as set forth on Schedule
      3.1(v),
      neither
      the Company nor any Subsidiary has granted or agreed to grant to any Person
      any
      rights (including “piggy-back” registration rights) to have any securities of
      the Company registered with the Commission or any other governmental authority
      that have not been satisfied.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    (w) Listing
      and Maintenance Requirements.
      Except
      as specified in the SEC Reports, the Company has not, since February 13, 2007,
      received notice from any Trading Market to the effect that the Company is not
      in
      compliance with the listing, quoting or maintenance requirements thereof. The
      Company is, and has no reason to believe that it will not in the foreseeable
      future continue to be, in compliance with the listing, quoting or maintenance
      requirements for continued listing or quoting of the Common Stock on the Trading
      Market on which the Common Stock is currently listed or quoted. The issuance
      and
      sale of the Securities under the Transaction Documents does not contravene
      the
      rules and regulations of the Trading Market on which the Common Stock is
      currently listed or quoted, and no approval of the shareholders of the Company
      thereunder is required for the Company to issue and deliver to the Investors
      the
      Securities contemplated by Transaction Documents.

     

    (x) Investment
      Company.
      The
      Company and each Subsidiary is not, and is not an Affiliate of, and immediately
      following the Closing will not have become, an “investment company” within the
      meaning of the Investment Company Act of 1940, as amended.

     

    (y) Application
      of Takeover Protections.
      The
      Company has taken all necessary action, if any, in order to render inapplicable
      any control share acquisition, business combination, poison pill (including
      any
      distribution under a rights agreement) or other similar anti-takeover provision
      under the Company’s Certificate of Incorporation (or similar charter documents)
      or the laws of its state of incorporation that is or could become applicable
      to
      the Investors as a result of the Investors and the Company fulfilling their
      obligations or exercising their rights under the Transaction Documents,
      including without limitation the Company’s issuance of the Securities and the
      Investors’ ownership of the Securities.

     

    (z) No
      Additional Agreements.
      The
      Company does not have any agreement or understanding with any Investor with
      respect to the transactions contemplated by the Transaction Documents other
      than
      as specified in the Transaction Documents.

     

    (aa) Consultation
      with Auditors.
      The
      Company and each Subsidiary has consulted its independent auditors concerning
      the accounting treatment of the transactions contemplated by the Transaction
      Documents, and in connection therewith has furnished such auditors complete
      copies of the Transaction Documents.

     

    (bb) Foreign
      Corrupt Practices Act.
      Neither
      the Company nor any Subsidiary, nor to the knowledge of the Company, any agent
      or other person acting on behalf of any of the Company or any Subsidiary, has,
      directly or indirectly, (i) used any funds, or will use any proceeds from the
      sale of the Securities, for unlawful contributions, gifts, entertainment or
      other unlawful expenses related to foreign or domestic political activity,
      (ii)
      made any unlawful payment to foreign or domestic government officials or
      employees or to any foreign or domestic political parties or campaigns from
      corporate funds, (iii) failed to disclose fully any contribution made by the
      Company or any Subsidiary (or made by any Person acting on their behalf of
      which
      the Company is aware) which is in violation of law, or (iv) has violated in
      any
      material respect any provision of the Foreign Corrupt Practices Act of 1977,
      as
      amended, and the rules and regulations thereunder.

     

    (cc) PFIC.
      Neither
      the Company nor any Subsidiary is or intends to become a “passive foreign
      investment company” within the meaning of Section 1297 of the U.S. Internal
      Revenue Code of 1986, as amended.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    (dd) OFAC.
      Neither
      the Company nor any Subsidiary nor, to the knowledge of the Company, any
      director, officer, agent, employee, Affiliate or Person acting on behalf of
      the
      Company or any Subsidiary is currently subject to any U.S. sanctions
      administered by the Office of Foreign Assets Control of the U.S. Treasury
      Department (“OFAC”);
      and
      the Company will not directly or indirectly use the proceeds of the sale of
      the
      Securities, or lend, contribute or otherwise make available such proceeds to
      any
      Subsidiary, joint venture partner or other Person or entity, towards any sales
      or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country
      sanctioned by OFAC or for the purpose of financing the activities of any Person
      currently subject to any U.S. sanctions administered by OFAC.

     

    (ee) Money
      Laundering Laws.
      The
      operations of each of the Company and any Subsidiary are and have been conducted
      at all times in compliance with the money laundering statutes of applicable
      jurisdictions, the rules and regulations thereunder and any related or similar
      rules, regulations or guidelines, issued, administered or enforced by any
      applicable governmental agency (collectively, the “Money
      Laundering Laws”)
      and no
      action, suit or proceeding by or before any court or governmental agency,
      authority or body or any arbitrator involving the Company and/or any Subsidiary
      with respect to the Money Laundering Laws is pending or, to the best knowledge
      of the Company, threatened.

     

    (ff) Disclosure.
      The
      Company (on behalf of each Subsidiary) confirms that neither it nor any Person
      acting on its behalf has provided any Investor or its respective agents or
      counsel with any information that the Company believes constitutes material,
      non-public information except insofar as the existence and terms of the proposed
      transactions hereunder may constitute such information. The Company understands
      and confirms that the Investors will rely on the foregoing representations
      and
      covenants in effecting transactions in securities of the Company. All disclosure
      provided to the Investors regarding the Company (including each Subsidiary),
      its
      and any Subsidiary’s business and the transactions contemplated hereby,
      furnished by or on behalf of the Company (including the Company’s
      representations and warranties set forth in this Agreement) are true and correct
      and do not contain any untrue statement of a material fact or omit to state
      any
      material fact necessary in order to make the statements made therein, in light
      of the circumstances under which they were made, not misleading.

     

    3.2. Representations
      and Warranties of the Investors.
      Each
      Investor hereby, for itself and for no other Investor, represents and warrants
      to the Company as follows:

     

    (a) Organization;
      Authority.
      Such
      Investor is an entity duly organized, validly existing and in good standing
      under the laws of the jurisdiction of its organization with the requisite
      corporate or partnership power and authority to enter into and to consummate
      the
      transactions contemplated by the applicable Transaction Documents and otherwise
      to carry out its obligations thereunder. The
      execution,
      delivery and performance by such Investor of
      the
      transactions contemplated by
      this
      Agreement has been
      duly
      authorized by all necessary corporate or, if such Investor is not a corporation,
      such partnership, limited liability company or other applicable like action,
      on
      the part of such Investor.
      This
      Agreement has been duly executed by each such Investor, and when delivered
      by
      such Investor in accordance with the terms hereof, will constitute the valid
      and
      legally binding obligation of such Investor, enforceable against it in
      accordance with its terms, except as such enforceability may be limited by
      applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
      or
      similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general
      application.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (b) Investment
      Intent.
      Such
      Investor is acquiring the Securities as principal for its own account for
      investment purposes only and not with a view to or for distributing or reselling
      such Securities or any part thereof, without prejudice, however, to such
      Investor’s right at all times to sell or otherwise dispose of all or any part of
      such Securities in compliance with applicable federal and state securities
      laws.
      Subject to the immediately preceding sentence, nothing contained herein shall
      be
      deemed a representation or warranty by such Investor to hold the Securities
      for
      any period of time. Such Investor is acquiring the Securities hereunder in
      the
      ordinary course of its business. Such Investor does not have any agreement
      or
      understanding, directly or indirectly, with any Person to distribute any of
      the
      Securities.

     

    (c) Investor
      Status.
      At the
      time such Investor was offered the Securities, it was, and at the date hereof
      it
      is, and on each date on which it exercises Warrants it will be, an “accredited
      investor” as defined in Rule 501(a) under the Securities Act. Such Investor is
      not a registered broker-dealer under Section 15 of the Exchange
      Act.

     

    (d) General
      Solicitation.
      Such
      Investor is not purchasing the Securities as a result of any advertisement,
      article, notice or other communication regarding the Securities published in
      any
      newspaper, magazine or similar media or broadcast over television or radio
      or
      presented at any seminar or any other general solicitation or general
      advertisement.

     

    (e) Access
      to Information.
      Such
      Investor acknowledges that it has reviewed the Disclosure Materials and has
      been
      afforded (i) the opportunity to ask such questions as it has deemed necessary
      of, and to receive answers from, representatives of the Company concerning
      the
      terms and conditions of the offering of the Shares and the merits and risks
      of
      investing in the Securities; (ii) access to information about the Company and
      the Subsidiaries and their respective financial condition, results of
      operations, business, properties, management and prospects sufficient to enable
      it to evaluate its investment; and (iii) the opportunity to obtain such
      additional information that the Company possesses or can acquire without
      unreasonable effort or expense that is necessary to make an informed investment
      decision with respect to the investment. Neither such inquiries nor any other
      investigation conducted by or on behalf of such Investor or its representatives
      or counsel shall modify, amend or affect such Investor’s right to rely on the
      truth, accuracy and completeness of the Disclosure Materials and the Company’s
      representations and warranties contained in the Transaction
      Documents.

     

    (f) Certain
      Trading Activities.
      Such
      Investor has not directly or indirectly, nor has any Person acting on behalf
      of
      or pursuant to any understanding with such Investor, engaged in any transactions
      in the securities of the Company (including, without limitations, any Short
      Sales involving the Company’s securities) since the earlier to occur of (1) the
      time that such Investor was first contacted by the Company or a finder for
      the
      Company regarding the transactions contemplated by this Agreement and (2) the
      30th
      day
      prior to the date of this Agreement. Such Investor covenants that neither it
      nor
      any Person acting on its behalf or pursuant to any understanding with it will
      engage in any transactions in the securities of the Company (including Short
      Sales) prior to the time that the transactions contemplated by this Agreement
      are publicly disclosed.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    (g) Independent
      Investment Decision.
      Such
      Investor has independently evaluated the merits of its decision to purchase
      the
      Securities pursuant to the Transaction Documents, and such Investor confirms
      that it has not relied on the advice of any other Investor’s business and/or
      legal counsel in making such decision. Such Investor has not relied on the
      business or legal advice of any finder for the Company or any of its agents,
      counsel or Affiliates in making its investment decision hereunder, and confirms
      that none of such Persons has made any representations or warranties to such
      Investor in connection with the transactions contemplated by the Transaction
      Documents.

     

    The
      Company acknowledges and agrees that no Investor has made or makes any
      representations or warranties with respect to the transactions contemplated
      hereby other than those specifically set forth in this Section 3.2.

     

    ARTICLE
      4.

     

    OTHER
      AGREEMENTS OF THE PARTIES

     

    4.1.
      (a)
Securities
      may only be disposed of in compliance with state and federal securities laws.
      In
      connection with any transfer of the Securities other than pursuant to an
      effective registration statement, to the Company, to an Affiliate of an Investor
      or in connection with a pledge as contemplated in Section 4.1(b), the Company
      may require the transferor thereof to provide to the Company an opinion of
      counsel selected by the transferor, the form and substance of which opinion
      shall be reasonably satisfactory to the Company, to the effect that such
      transfer does not require registration of such transferred Securities under
      the
      Securities Act.

     

    (b) Certificates
      evidencing the Securities will contain the following legend, until such time
      as
      they are not required under Section 4.1(c):

     

    [NEITHER
      THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES
      HAVE BEEN REGISTERED] [THESE SECURITIES HAVE NOT BEEN REGISTERED] WITH THE
      SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
      IN
      RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
      AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
      EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT
      OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO,
      THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY. [THESE SECURITIES AND THE SECURITIES ISSUABLE UPON
      EXERCISE OF THESE SECURITIES] [THESE SECURITIES] MAY BE PLEDGED IN CONNECTION
      WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    The
      Company acknowledges and agrees that an Investor may from time to time pledge,
      and/or grant a security interest in some or all of the Securities pursuant
      to a
      bona fide margin agreement in connection with a bona fide margin account and,
      if
      required under the terms of such agreement or account, such Investor may
      transfer pledged or secured Securities to the pledgees or secured parties.
      Such
      a pledge or transfer would not be subject to approval or consent of the Company
      and no legal opinion of legal counsel to the pledgee, secured party or pledgor
      shall be required in connection with the pledge, but such legal opinion may
      be
      required in connection with a subsequent transfer following default by the
      Investor transferee of the pledge. No notice shall be required of such pledge.
      At the appropriate Investor’s expense, the Company will execute and deliver such
      reasonable documentation as a pledgee or secured party of Securities may
      reasonably request in connection with a pledge or transfer of the Securities.
      Except as otherwise provided in Section 4.1(c), any Shares subject to a pledge
      or security interest as contemplated by this Section 4.1(b) shall continue
      to
      bear the legend set forth in this Section 4.1(b) and be subject to the
      restrictions on transfer set forth in Section 4.1(a).

     

    (c) Certificates
      evidencing Shares shall not contain any legend (including the legend set forth
      in Section 4.1(b)): (i) following a sale or transfer of such Shares pursuant
      to
      an effective registration statement, or (ii) following a sale or transfer of
      such Shares pursuant to Rule 144 (assuming the transferee is not an Affiliate
      of
      the Company), or (iii) while such Shares are eligible for sale under Rule
      144(k). If
      an
      Investor shall make a sale or transfer of Shares either (x) pursuant to Rule
      144
      or (y) pursuant to a registration statement and in each case shall have
      delivered to the Company or the Company’s transfer agent the certificate
      representing Shares containing a restrictive legend which are the subject of
      such sale or transfer
      and a representation letter in customary form (the
      date of
      such sale or transfer and Share delivery being the “Share
      Delivery Date”)
      and (1)
      the Company shall fail to deliver or cause to be delivered to such Investor
      a
      certificate representing such Shares that is free from all restrictive or other
      legends by the third Trading Day following the Share Delivery Date and (2)
      following such third Trading Day after the Share Delivery Date and prior to
      the
      time such Shares are received free from restrictive legends, the Investor,
      or
      any third party on behalf of such Investor, purchases (in an open market
      transaction or otherwise) shares of Common Stock to deliver in satisfaction
      of a
      sale by the Investor of such Shares (a "Buy-In"),
      then
      the Company shall pay in cash to the Investor (for costs incurred either
      directly by such Investor or on behalf of a third party) the amount by which
      the
      total purchase price paid for Common Stock as a result of the Buy-In (including
      brokerage commissions, if any) exceed the proceeds received by such Investor
      as
      a result of the sale to which such Buy-In relates. The Investor shall provide
      the Company written notice indicating the amounts payable to the Investor in
      respect of the Buy-In.

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    4.2. Furnishing
      of Information.
      As long
      as any Investor owns the Securities, the Company covenants to timely file (or
      obtain extensions in respect thereof and file within the applicable grace
      period) all reports required to be filed by the Company after the date hereof
      pursuant to the Exchange Act. As long as any Investor owns Securities, if the
      Company is not required to file reports pursuant to such laws, it will prepare
      and furnish to the Investors and make publicly available in accordance with
      Rule
      144(c) such information as is required for the Investors to sell the Shares
      and
      Warrant Shares under Rule 144. The Company further covenants that it will take
      such further action as any holder of Securities may reasonably request, all
      to
      the extent required from time to time to enable such Person to sell the Shares
      and Warrant Shares without registration under the Securities Act within the
      limitation of the exemptions provided by Rule 144.

     

    4.3. Integration.
      The
      Company shall not, and shall use its best efforts to ensure that no Affiliate
      of
      the Company shall, sell, offer for sale or solicit offers to buy or otherwise
      negotiate in respect of any security (as defined in Section 2 of the Securities
      Act) that would be integrated with the offer or sale of the Securities in a
      manner that would require the registration under the Securities Act of the
      sale
      of the Securities to the Investors, or that would be integrated with the offer
      or sale of the Securities for purposes of the rules and regulations of any
      Trading Market in a manner that would require stockholder approval of the sale
      of the securities to the Investors.

     

    4.4. Securities
      Laws Disclosure; Publicity.
      By 9:00
      a.m. (New York time) four (4) Trading Days following the execution of this
      Agreement, and by 9:00 a.m. (New York time) four (4) Trading Days following
      the
      Closing Date, the Company shall issue press releases disclosing the transactions
      contemplated hereby and the Closing. Within four (4) Trading Days following
      the
      execution of this Agreement the Company will file a Current Report on Form
      8-K
      disclosing the material terms of the Transaction Documents (and attach as
      exhibits thereto the Transaction Documents), and within four (4) Trading Days
      following the Closing Date the Company will file an additional Current Report
      on
      Form 8-K to disclose the Closing (unless this Agreement is executed on the
      same
      date as the Closing Date, in which case only one Form 8-K disclosing the
      execution of this Agreement and the Closing need be filed). In addition, the
      Company will make such other filings and notices in the manner and time required
      by the Commission and the Trading Market on which the Common Stock is quoted
      or
      listed. Notwithstanding the foregoing, the Company shall not publicly disclose
      the name of any Investor, or include the name of any Investor in any filing
      with
      the Commission or any regulatory agency or Trading Market, without the prior
      written consent of such Investor, except to the extent such disclosure is
      required by law or Trading Market regulations.

     

    4.5. Limitation
      on Issuance of Future Priced Securities.
      During
      the six months following the Closing Date, the Company shall not issue any
      “Future Priced Securities” as such term is described by NASD
      IM-4350-1.

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

     

    4.6. Indemnification
      of Investors.
      The
      Company will indemnify and hold the Investors and their directors, officers,
      shareholders, partners, employees and agents (each, an “Investor
      Party”)
      harmless from any and all losses, liabilities, obligations, claims,
      contingencies, damages, costs and expenses, including all judgments, amounts
      paid in settlements, court costs and reasonable attorneys’ fees and costs of
      investigation (collectively, “Losses”)
      that
      any such Investor Party may suffer or incur as a result of or relating to any
      misrepresentation, breach or inaccuracy of any representation, warranty,
      covenant or agreement made by the Company in any Transaction Document. In
      addition to the indemnity contained herein, the Company will reimburse each
      Investor Party for its reasonable legal and other expenses (including the cost
      of any investigation, preparation and travel in connection therewith) incurred
      in connection therewith, as such expenses are incurred.

     

    4.7. Non-Public
      Information.
      The
      Company covenants and agrees that neither it nor any other Person acting on
      its
      behalf will provide any Investor or its agents or counsel with any information
      that the Company believes constitutes material non-public information, unless
      prior thereto such Investor shall have executed a written agreement regarding
      the confidentiality and use of such information. The Company understands and
      confirms that each Investor shall be relying on the foregoing representations
      in
      effecting transactions in securities of the Company.

     

    4.8. Listing
      of Securities.
      The
      Company agrees, (i) if the Company applies to have the Common Stock listed
      or
      quoted on any Trading Market, other than the Trading Market on which the Common
      Stock is currently listed or quoted, it will include in such application the
      Shares and Warrant Shares, and will take such other action as is necessary
      or
      desirable to cause the Shares and Warrant Shares to be listed or quoted on
      such
      other Trading Market as promptly as possible, and (ii) it will take all action
      reasonably necessary to continue the listing or quoting of its Common Stock
      on a
      Trading Market and will comply in all material respects with the Company’s
      reporting, filing and other obligations under the bylaws or rules of the Trading
      Market.

     

    4.9. Use
      of
      Proceeds.
      The
      Company will use the net proceeds from the sale of the Securities hereunder
      for
      working capital purposes and not for the satisfaction of any portion of the
      Company’s debt (other than payment of trade payables and accrued expenses in the
      ordinary course of the Company’s business and consistent with prior
      practices),
      or
      to
      redeem any Common Stock or Common Stock Equivalents.

     

    4.10. Right
      of First Refusal. (a) Any Investor whose aggregate Investment Amount, when
      combined with the aggregate investment amount, if any, set forth on such
      Investor’s signature page to that certain Securities Purchase Agreement dated as
      of June 26, 2007 and October 12, 2007, among the Company and the investors
      identified on the signature pages thereto, is equal to or greater than Five
      Million Dollars ($5,000,000.00) (“Preferred
      Investor”)
      shall
      have the following right of first refusal. During the twelve (12) month period
      immediately following the Closing, each Preferred Investor shall be given not
      less than ten (10) Business Days prior written notice of any proposed sale
      by
      the Company of its Common Stock, except in connection with any Excepted
      Issuances (as defined below). Any Preferred Investor who exercises its rights
      pursuant to this Section 4.11 shall have the right during the ten (10) Business
      Days following the aforesaid notice to purchase all (not a portion) of the
      offered Common Stock upon the same terms and conditions set forth in the notice.
      If there is more than one (1) Preferred Investor who wishes to exercise such
      right, then the total investment shall be allocated among them in proportion
      to
      their aggregate Investment Amounts as indicated on each such Investor’s
      signature page to this Agreement.

     

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

    

     

    (b) For
      purposes of this Section 4.11, Excepted Issuances shall mean (i) issuance of
      securities as full or partial consideration in connection with a merger,
      acquisition, consolidation or purchase of substantially all of the securities
      or
      assets of a corporation or other entity, (ii) the Company’s issuance of
      securities in connection with strategic license agreements and other partnering
      arrangements and financial institutions in connection with credit or financing
      transactions, (iii) the Company’s issuance of securities or the issuances or
      grants of options to purchase securities to the Company’s employees, officers,
      directors or consultants, (iv) issuances as a result of the exercise of and/or
      conversion of any and all of the Company’s convertible securities presently
      outstanding, those issued in connection with the transactions contemplated
      by
      this Agreement (including any warrants issued to any finder as compensation
      in
      connection with the financing that is the subject of this Agreement) and those
      issued in the future, and (v) securities issued in connection with stock splits,
      dividends and combinations.

     

    ARTICLE
      5.

    CONDITIONS
      PRECEDENT TO CLOSING

     

    5.1. Conditions
      Precedent to the Obligations of the Investors to Purchase
      Securities.
      The
      obligation of each Investor to acquire Securities at the Closing is subject
      to
      the satisfaction or waiver by such Investor, at or before the Closing, of each
      of the following conditions:

     

    (a) Representations
      and Warranties.
      The
      representations and warranties of the Company contained herein shall be true
      and
      correct in all material respects as of the date when made and as of the Closing
      as though made on and as of such date;

     

    (b) Performance.
      The
      Company shall have performed, satisfied and complied in all material respects
      with all covenants, agreements and conditions required by the Transaction
      Documents to be performed, satisfied or complied with by it at or prior to
      the
      Closing;

     

    (c) No
      Injunction.
      No
      statute, rule, regulation, executive order, decree, ruling or injunction shall
      have been enacted, entered, promulgated or endorsed by any court or governmental
      authority of competent jurisdiction that prohibits the consummation of any
      of
      the transactions contemplated by the Transaction Documents;

     

    (d) Adverse
      Changes.
      Since
      the date of execution of this Agreement, no event or series of events shall
      have
      occurred that reasonably could have or result in a Material Adverse
      Effect;

     

    (e) No
      Suspensions of Trading in Common Stock; Listing.
      Trading
      in the Common Stock shall not have been suspended by the Commission or any
      Trading Market (except for any suspensions of trading of not more than one
      Trading Day solely to permit dissemination of material information regarding
      the
      Company) at any time since the date of execution of this Agreement, and the
      Common Stock shall have been at all times since such date listed or quoted
      for
      trading on a Trading Market;

     

    (f) Company
      Deliverables.
      The
      Company shall have delivered the Company Deliverables in accordance with Section
      2.2(a); and

     

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

     

    (g) Termination.
      This
      Agreement shall not have been terminated as to such Investor in accordance
      with
      Section 6.5.

     

    5.2. Conditions
      Precedent to the Obligations of the Company to sell Securities.
      The
      obligation of the Company to sell Securities at the Closing is subject to the
      satisfaction or waiver by the Company, at or before the Closing, of each of
      the
      following conditions:

     

    (a) Representations
      and Warranties.
      The
      representations and warranties of each Investor contained herein shall be true
      and correct in all material respects as of the date when made and as of the
      Closing Date as though made on and as of such date;

     

    (b) Performance.
      Each
      Investor shall have performed, satisfied and complied in all material respects
      with all covenants, agreements and conditions required by the Transaction
      Documents to be performed, satisfied or complied with by such Investor at or
      prior to the Closing;

     

    (c) No
      Injunction.
      No
      statute, rule, regulation, executive order, decree, ruling or injunction shall
      have been enacted, entered, promulgated or endorsed by any court or governmental
      authority of competent jurisdiction that prohibits the consummation of any
      of
      the transactions contemplated by the Transaction Documents;

     

    (d) Investors
      Deliverables.
      Each
      Investor shall have delivered its Investors Deliverables in accordance with
      Section 2.2(b); and

     

    (e) Termination.
      This
      Agreement shall not have been terminated as to such Investor in accordance
      with
      Section 6.5.

     

    ARTICLE
      6.

    MISCELLANEOUS

     

    6.1. Fees
      and Expenses.
      Each
      party shall pay the fees and expenses of its advisers, counsel, accountants
      and
      other experts, if any, and all other expenses incurred by such party incident
      to
      the negotiation, preparation, execution, delivery and performance of the
      Transaction Documents. The Company shall pay all stamp and other taxes and
      duties levied in connection with the issuance of the Securities.

     

    6.2. Entire
      Agreement.
      The
      Transaction Documents, together with the exhibits and schedules thereto, contain
      the entire understanding of the parties with respect to the subject matter
      hereof and supersede all prior agreements, understandings, discussions and
      representations, oral or written, with respect to such matters, which the
      parties acknowledge have been merged into such documents, exhibits and
      schedules.

     

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

     

    6.3. Notices.
      Any and
      all notices or other communications or deliveries required or permitted to
      be
      provided hereunder shall be in writing and shall be deemed given and effective
      on the earliest of (a) the date of transmission, if such notice or communication
      is delivered via facsimile (provided the sender receives a machine-generated
      confirmation of successful transmission) at the facsimile number specified
      in
      this Section prior to 6:30 p.m. (New York City time) on a Trading Day, (b)
      the
      next Trading Day after the date of transmission, if such notice or communication
      is delivered via facsimile at the facsimile number specified in this Section
      on
      a day that is not a Trading Day or later than 6:30 p.m. (New York City time)
      on
      any Trading Day, (c) the Trading Day following the date of mailing, if sent
      by
      U.S. nationally recognized overnight courier service, or (d) upon actual receipt
      by the party to whom such notice is required to be given. The address for such
      notices and communications shall be as follows:

     

    
      
        	 	
                If
                  to the Company:

              	
                Organic
                  To Go Food Corporation

              
	 	 	
                3317
                  Third Avenue South

              
	 	 	
                Seattle,
                  Washington 98134

              
	 	 	
                Attn:
                  Chief Executive Officer

              
	 	 	
                Facsimile: (206)
                  838-4695

              
	 	 	 
	 	
                With
                  a copy to:

              	
                Loeb
                  & Loeb LLP

              
	 	 	
                10100
                  Santa Monica Boulevard

              
	 	 	
                Suite
                  2200

              
	 	 	
                Los
                  Angeles, California 90067

              
	 	 	
                Attention:
                  Gerald
                  M. Chizever, Esq.

              
	 	
              	
                Facsimile:
                  (310) 282-2200

              
	 	 	 
	 	
                If
                  to an Investor:

              	
                To
                  the address set forth under such Investor’s name on the signature pages
                  hereof;

              

      

       

    

    
    

    or
      such
      other address as may be designated in writing hereafter, in the same manner,
      by
      such Person.

     

    6.4. Amendments;
      Waivers; No Additional Consideration.
      No
      provision of this Agreement may be waived or amended except in a written
      instrument signed by the Company and the Investors holding a majority of the
      Shares. No waiver of any default with respect to any provision, condition or
      requirement of this Agreement shall be deemed to be a continuing waiver in
      the
      future or a waiver of any subsequent default or a waiver of any other provision,
      condition or requirement hereof, nor shall any delay or omission of either
      party
      to exercise any right hereunder in any manner impair the exercise of any such
      right. No consideration shall be offered or paid to any Investor to amend or
      consent to a waiver or modification of any provision of any Transaction Document
      unless the same consideration is also offered to all Investors who then hold
      Shares.

     

    6.5. Termination.
      This
      Agreement may be terminated prior to Closing:

     

    (a) by
      written agreement of the Investors and the Company; and

     

    (b) by
      the
      Company or an Investor (as to itself but no other Investor) upon written notice
      to the other and to the Escrow Agent, if the Closing shall not have taken place
      by 6:30 p.m. Eastern time on the Outside Date; provided,
      that
      the right to terminate this Agreement under this Section 6.5(b) shall not
      be available to any Person whose failure to comply with its obligations under
      this Agreement has been the cause of or resulted in the failure of the Closing
      to occur on or before such time.

     

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

     

    In
      the
      event of a termination pursuant to this Section, the Company shall promptly
      notify all non-terminating Investors. Upon a termination in accordance with
      this
      Section 6.5, the Company and the terminating Investor(s) shall not have any
      further obligation or liability (including as arising from such termination)
      to
      the other and no Investor will have any liability to any other Investor under
      the Transaction Documents as a result therefrom.

     

    6.6. Construction.
      The
      headings herein are for convenience only, do not constitute a part of this
      Agreement and shall not be deemed to limit or affect any of the provisions
      hereof. The language used in this Agreement will be deemed to be the language
      chosen by the parties to express their mutual intent, and no rules of strict
      construction will be applied against any party. This Agreement shall be
      construed as if drafted jointly by the parties, and no presumption or burden
      of
      proof shall arise favoring or disfavoring any party by virtue of the authorship
      of any provisions of this Agreement or any of the Transaction
      Documents.

     

    6.7. Successors
      and Assigns.
      This
      Agreement shall be binding upon and inure to the benefit of the parties and
      their successors and permitted assigns. The Company may not assign this
      Agreement or any rights or obligations hereunder without the prior written
      consent of the Investors. Any Investor may assign any or all of its rights
      under
      this Agreement to any Person to whom such Investor assigns or transfers any
      Securities, provided such transferee agrees in writing to be bound, with respect
      to the transferred Securities, by the provisions hereof that apply to the
“Investors.”

     

    6.8. No
      Third-Party Beneficiaries.
      This
      Agreement is intended for the benefit of the parties hereto and their respective
      successors and permitted assigns and is not for the benefit of, nor may any
      provision hereof be enforced by, any other Person, except as otherwise set
      forth
      in Section 4.7 (as to each Investor Party).

     

    6.9. Governing
      Law.
      All
      questions concerning the construction, validity, enforcement and interpretation
      of this Agreement shall be governed by and construed and enforced in accordance
      with the internal laws of the State of New York, without regard to the
      principles of conflicts of law thereof. Each party agrees that all Proceedings
      concerning the interpretations, enforcement and defense of the transactions
      contemplated by this Agreement and any other Transaction Documents (whether
      brought against a party hereto or its respective Affiliates, employees or
      agents) shall be commenced exclusively in the New York Courts. Each party hereto
      hereby irrevocably submits to the exclusive jurisdiction of the New York Courts
      for the adjudication of any dispute hereunder or in connection herewith or
      with
      any transaction contemplated hereby or discussed herein (including with respect
      to the enforcement of the any of the Transaction Documents), and hereby
      irrevocably waives, and agrees not to assert in any Proceeding, any claim that
      it is not personally subject to the jurisdiction of any such New York Court,
      or
      that such Proceeding has been commenced in an improper or inconvenient forum.
      Each party hereto hereby irrevocably waives personal service of process and
      consents to process being served in any such Proceeding by mailing a copy
      thereof via registered or certified mail or overnight delivery (with evidence
      of
      delivery) to such party at the address in effect for notices to it under this
      Agreement and agrees that such service shall constitute good and sufficient
      service of process and notice thereof. Nothing contained herein shall be deemed
      to limit in any way any right to serve process in any manner permitted by law.
      Each party hereto hereby irrevocably waives, to the fullest extent permitted
      by
      applicable law, any and all right to trial by jury in any legal proceeding
      arising out of or relating to this Agreement or the transactions contemplated
      hereby. If either party shall commence a Proceeding to enforce any provisions
      of
      a Transaction Document, then the prevailing party in such Proceeding shall
      be
      reimbursed by the other party for its reasonable attorneys’ fees and other costs
      and expenses incurred with the investigation, preparation and prosecution of
      such Proceeding.

     

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

    

     

    6.10. Survival.
      The
      representations, warranties, agreements and covenants contained herein shall
      survive the Closing and the delivery of the Securities.

     

    6.11. Execution.
      This
      Agreement may be executed in two or more counterparts, all of which when taken
      together shall be considered one and the same agreement and shall become
      effective when counterparts have been signed by each party and delivered to
      the
      other party, it being understood that both parties need not sign the same
      counterpart. In the event that any signature is delivered by facsimile or
      electronic mail transmission, such signature shall create a valid and binding
      obligation of the party executing (or on whose behalf such signature is
      executed) with the same force and effect as if such facsimile or electronic
      mail
      signature page were an original thereof.

     

    6.12. Severability.
      If any
      provision of this Agreement is held to be invalid or unenforceable in any
      respect, the validity and enforceability of the remaining terms and provisions
      of this Agreement shall not in any way be affected or impaired thereby and
      the
      parties will attempt to agree upon a valid and enforceable provision that is
      a
      reasonable substitute therefor, and upon so agreeing, shall incorporate such
      substitute provision in this Agreement.

     

    6.13. Rescission
      and Withdrawal Right.
      Notwithstanding anything to the contrary contained in (and without limiting
      any
      similar provisions of) the Transaction Documents, whenever any Investor
      exercises a right, election, demand or option under a Transaction Document
      and
      the Company does not timely perform its related obligations within the periods
      therein provided, then such Investor may rescind or withdraw, in its sole
      discretion from time to time upon written notice to the Company, any relevant
      notice, demand or election in whole or in part without prejudice to its future
      actions and rights.

     

    6.14. Replacement
      of Securities.
      If any
      certificate or instrument evidencing any Securities is mutilated, lost, stolen
      or destroyed, the Company shall issue or cause to be issued in exchange and
      substitution for and upon cancellation thereof, or in lieu of and substitution
      therefor, a new certificate or instrument, but only upon receipt of evidence
      reasonably satisfactory to the Company of such loss, theft or destruction and
      customary and reasonable indemnity, if requested. The applicants for a new
      certificate or instrument under such circumstances shall also pay any reasonable
      third-party costs associated with the issuance of such replacement Securities.
      If a replacement certificate or instrument evidencing any Securities is
      requested due to a mutilation thereof, the Company may require delivery of
      such
      mutilated certificate or instrument as a condition precedent to any issuance
      of
      a replacement.

     

    6.15. Remedies.
      In
      addition to being entitled to exercise all rights provided herein or granted
      by
      law, including recovery of damages, each of the Investors and the Company will
      be entitled to specific performance under the Transaction Documents. The parties
      agree that monetary damages may not be adequate compensation for any loss
      incurred by reason of any breach of obligations described in the foregoing
      sentence and hereby agrees to waive in any action for specific performance
      of
      any such obligation the defense that a remedy at law would be
      adequate.

     

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

     

    6.16. Payment
      Set Aside.
      To the
      extent that the Company makes a payment or payments to any Investor pursuant
      to
      any Transaction Document or an Investor enforces or exercises its rights
      thereunder, and such payment or payments or the proceeds of such enforcement
      or
      exercise or any part thereof are subsequently invalidated, declared to be
      fraudulent or preferential, set aside, recovered from, disgorged by or are
      required to be refunded, repaid or otherwise restored to the Company, a trustee,
      receiver or any other person under any law (including, without limitation,
      any
      bankruptcy law, state or federal law, common law or equitable cause of action),
      then to the extent of any such restoration the obligation or part thereof
      originally intended to be satisfied shall be revived and continued in full
      force
      and effect as if such payment had not been made or such enforcement or setoff
      had not occurred.

     

    6.17. Independent
      Nature of Investors’ Obligations and Rights.
      The
      obligations of each Investor under any Transaction Document are several and
      not
      joint with the obligations of any other Investor, and no Investor shall be
      responsible in any way for the performance of the obligations of any other
      Investor under any Transaction Document. The decision of each Investor to
      purchase Securities pursuant to the Transaction Documents has been made by
      such
      Investor independently of any other Investor. Nothing contained herein or in
      any
      Transaction Document, and no action taken by any Investor pursuant thereto,
      shall be deemed to constitute the Investors as a partnership, an association,
      a
      joint venture or any other kind of entity, or create a presumption that the
      Investors are in any way acting in concert or as a group with respect to such
      obligations or the transactions contemplated by the Transaction Documents.
      Each
      Investor acknowledges that no other Investor has acted as agent for such
      Investor in connection with making its investment hereunder and that no Investor
      will be acting as agent of such Investor in connection with monitoring its
      investment in the Securities or enforcing its rights under the Transaction
      Documents. Each Investor shall be entitled to independently protect and enforce
      its rights, including without limitation the rights arising out of this
      Agreement or out of the other Transaction Documents, and it shall not be
      necessary for any other Investor to be joined as an additional party in any
      proceeding for such purpose. The Company acknowledges that each of the Investors
      has been provided with the same Transaction Documents for the purpose of closing
      a transaction with multiple Investors and not because it was required or
      requested to do so by any Investor.

     

    6.18. Limitation
      of Liability.
      Notwithstanding anything herein to the contrary, the Company acknowledges and
      agrees that the liability of an Investor arising directly or indirectly, under
      any Transaction Document of any and every nature whatsoever shall be satisfied
      solely out of the assets of such Investor, and that no trustee, officer, other
      investment vehicle or any other Affiliate of such Investor or any investor,
      shareholder or holder of shares of beneficial interest of such a Investor shall
      be personally liable for any liabilities of such Investor.

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK

    SIGNATURE
      PAGES FOLLOW]

     

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

    

    IN
      WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
      Agreement to be duly executed by their respective authorized signatories as
      of
      the date first indicated above.

    
      	 	 	 
	 	ORGANIC TO GO FOOD
              CORPORATION
	 
 	 
 	 
 
	 	By:  	 
	 	
              
Name:
              Jason Brown
	 	Title: Chairman and Chief Executive
              Officer

    

     

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK

    SIGNATURE
      PAGES FOR INVESTORS FOLLOW]

     

    Signature
      Page to Securities Purchase
      Agreement

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    

    IN
      WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
      Agreement to be duly executed by their respective authorized signatories as
      of
      the date first indicated above.

     

    

      
        	 	
                NAME
                  OF INVESTOR

              
	 	
                 

              
	 	___________________________________
	 	 
	 	
                By: 
                  _____________________________________

              
	 	
                Name:

              
	 	
                Title:

              
	 	 
	 	
                Investment
                  Amount: $________________________

              
	 	 
	 	
                Tax
                  ID No.:________________________________

              
	 	 
	 	
                ADDRESS
                  FOR NOTICE

              
	 	 
	 	
                c/o:______________________________________

              
	 	 
	 	
                Street:____________________________________

              
	 	 
	 	
                City/State/Zip:_____________________________

              
	 	 
	 	
                Attention:_________________________________

              
	 	 
	 	
                Tel:______________________________________

              
	 	 
	 	
                Fax:______________________________________

              
	 	 
	 	
                DELIVERY
                  INSTRUCTIONS

              
	 	 
	 	
                (if
                  different from above)

              
	 	 
	 	
                c/o:______________________________________

              
	 	 
	 	
                Street:____________________________________

              
	 	 
	 	
                City/State/Zip:_____________________________

              
	 	 
	 	
                Attention:_________________________________

              
	 	 
	 	
                Tel:______________________________________

              

      

       

    

    Signature
      Page to Securities Purchase
      Agreement

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Annex
      A

     

    SCHEDULE
      OF BUYERS

     

    
      	
              (1)

            	
              (2)

            
	
              Buyer

            	
               

              Address
                and

              Facsimile
                Number

            
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

    

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    EXHIBIT
      A

     

    Form
      of Warrant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]